Hatteras Investment Partners is an investment management firm focused on alternative investment strategies. In the provided content, there are several companies that have received investments from Hatteras, spanning industries like biopharmaceuticals, medical devices, and healthcare IT. This provides insights into Hatteras’ investment approach and areas of interest.
Hatteras Invests in Companies Developing Innovative Medical Devices
The medical device company CVRx received a $50 million investment from Hatteras Venture Partners. CVRx is developing an implantable device to treat problems like heart failure and hypertension. Another medical device company RapidAI received a $25 million Series B investment from Hatteras as well. RapidAI focuses on stroke imaging and analytics. From these investments, we can see that Hatteras has an interest in backing innovative medical device startups.
Biopharmaceuticals are a Major Investment Focus for Hatteras
In the content, there were several biopharmaceutical companies that received investments from Hatteras. These include Finch Therapeutics (microbiome therapeutics), Nurix Therapeutics (protein degradation), Kymera Therapeutics (protein degradation), and Variantyx (genetic disease testing). The breadth of investments indicates that biopharmaceuticals across various specific areas are a major investment focus for Hatteras.
Hatteras Also Invests in Healthcare IT and Diagnostics
Beyond medical devices and biopharmaceuticals, Hatteras has also invested in healthcare IT and diagnostics startups. For example, Olive, a healthcare IT company optimizing healthcare administration, received investment from Hatteras Venture Partners. Another diagnostics company Inflammatix, which is developing molecular diagnostic tests, was also backed by Hatteras. This demonstrates Hatteras’ interest expands across multiple healthcare verticals.
In summary, while Hatteras Investment Partners invests across industries, they have a particular focus on healthcare, including medical devices, biopharmaceuticals, healthcare IT, and diagnostics. Within healthcare, they look to back innovative and transformative startups across various specific verticals and therapeutic areas.